SUBSCRIBE
SUBSCRIBE

Postmarket research

Drug Development
Drug Combo of Herceptin and Tykerb Helps Women With Advanced Breast Cancer, Baylor-Sammons Cancer Center Study
May 16, 2008
 · 
1 min read
Drug Development
Doribax Shows Shorter Hospital Stays In Ventilator-Associated Pneumonia Patients, Johnson and Johnson Pharmaceutical Research and Development, LLC (NJ) Study
May 16, 2008
 · 
1 min read
Drug Development
Aprotinin Used In Heart Surgery Associated With Increased Risk Of Death, Ottawa Health Research Institute, The Ottawa Hospital, and University of Ottawa Study Shows
May 16, 2008
 · 
1 min read
Drug Development
Some Statins May Protect Against Cancer, McGill University Study
May 16, 2008
 · 
1 min read
Drug Development
Acne Drug Doxycycline Prevents Tissue Damage From Emphysema, Leeds University and University of California, San Diego (UCSD) Study
May 16, 2008
 · 
1 min read
Drug Development
Metformin Pill Effective Against Gestational Diabetes, Auckland City Hospital Study
May 8, 2008
 · 
1 min read
Drug Development
Ibuprofen Linked To Reduced Alzheimer’s Risk, Boston University School of Medicine Study
May 6, 2008
 · 
1 min read
Drug Development
Common Drugs Hasten Decline In Elderly, Wake Forest University School of Medicine Study
May 5, 2008
 · 
1 min read
Drug Development
Anti-Clotting Drug Cilostazol Found May Be Safer Than Aspirin Post-Stroke, Peking University Study
May 5, 2008
 · 
1 min read
Drug Development
Antidepressant Found To Alleviate Symptoms Of Irritable Bowel Syndrome In Adolescents, University of California, Los Angeles (UCLA) Study
May 2, 2008
 · 
1 min read
Load More
PRESS RELEASES
Drug Development
Celgene’s Abraxane is Talk of Cancer Meeting
October 1, 2012
 · 
1 min read
Drug Development
Cancer Trials Show One Year on Roche’s Herceptin is Best
October 1, 2012
 · 
1 min read
Drug Development
Pfizer Inc. Lung Cancer Drug Doubles Benefit, Researchers Say
October 1, 2012
 · 
1 min read
Drug Development
First Patient in Dendreon Corporation EU Open-Label Study Begins Sipuleucel-T Infusion Treatment
September 28, 2012
 · 
4 min read
Drug Development
Genomic Health, Inc. Announces Presentation of Three Oncotype DX® Studies in Breast and Colon Cancers at the 2012 European Society for Medical Oncology Congress
September 28, 2012
 · 
8 min read
Drug Development
New Janssen Pharmaceutica N.V. Data Demonstrate STELARA® (ustekinumab) is Effective, Well-Tolerated and Improved Quality of Life in Patients With Moderate to Severe Plaque Psoriasis
September 28, 2012
 · 
1 min read
Drug Development
Medicure Inc. Announces Development of Novel Aggrastat Formulation
September 26, 2012
 · 
10 min read
Drug Development
AstraZeneca PLC Release: New PLATO Sub-Analysis Suggests Patients’ Age Had No Impact on Study Finding of a Greater Reduction in Thrombotic Cardiovascular Events With BRILINTA (ticagrelor) Compared to Clopidogrel
September 24, 2012
 · 
1 min read
Drug Development
Pilot Study in Patients With Head and Neck Cancer Finds That Derma Sciences, Inc.’ MEDIHONEY® Reduces Hospital Stays in the U.K.
September 21, 2012
 · 
1 min read
Drug Development
FDA Lifts Temporary Hold on ViroPharma Incorporated Treatment
September 21, 2012
 · 
9 min read
Drug Development
Savient Pharmaceuticals, Inc. Announces Multiple Abstracts Related to KRYSTEXXA® in the Treatment of Refractory Chronic Gout to be Presented at the 2012 ACR/ARHP Annual Meeting
September 20, 2012
 · 
5 min read
Drug Development
JHP Pharmaceuticals to Produce Lyophilized Biologic for International Late-Phase Clinical Trials
September 19, 2012
 · 
1 min read
Drug Development
Cumberland Pharmaceuticals Release: Caldolor™ Reduces Narcotic Doses in Pediatric Pain Patients
September 19, 2012
 · 
3 min read
Drug Development
Spectrum Pharmaceuticals, Inc. Initiates Phase 3 Study of ZEVALIN® in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL); Most Common Form of Aggressive Non-Hodgkin’s Lymphoma
September 19, 2012
 · 
1 min read
Drug Development
Apricus Biosciences Announces Publication in Journal of Pharmaceutics and Drug Delivery Research
September 18, 2012
 · 
1 min read
Drug Development
New Study Demonstrating Progenra, Inc.'s Novel Anti-Tumor Compound Overcome VELCADE® (bortezomib) Resistant Multiple Myeloma Cells
September 17, 2012
 · 
1 min read
Drug Development
Genomic Health, Inc. Announces Presentation of Two Oncotype DX® Studies at the 2012 Breast Cancer Symposium
September 13, 2012
 · 
5 min read
Drug Development
AtriCure, Inc. Launches Three-Year Post-Approval Study for the Surgical Correction of Atrial Fibrillation
September 13, 2012
 · 
1 min read
Drug Development
NovaBay Pharmaceuticals, Inc.'s NeutroPhase® Used in New Therapeutic Technique for Management of Necrotizing Fasciitis
September 13, 2012
 · 
1 min read
Drug Development
Boehringer Ingelheim GmbH Release: Asian Populations With Atrial Fibrillation (AF) Benefit From Better Stroke Prevention With Pradaxa® (dabigatran etexilate) Compared to Warfarin
September 12, 2012
 · 
4 min read
Load More